Thursday, June 27, 2019

CBER Advanced Technologies Program

In regulating the pharmaceutical manufacturing sector, FDA realizes the need for a maximally efficient, agile, flexible pharmaceutical manufacturing sector that reliably produces high quality biologics.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2NhBaOc

No comments:

Post a Comment